Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YH14642 in Chronic Periodontal Disease (Phase II, 12-week Oral Administration)
KCT0001093Phase 2Completed
- Sponsor
- Yuhan
- Start
- Jan 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YH14642 in chronic periodontitis, sponsored by Yuhan. Started Jan 2012; status: completed.
02
Drugs
YH14642
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on KCT0001093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001093.